About 22nd Century
22nd Century is a company based in Williamsville (United States) founded in 1998. The company has 56 employees as of December 31, 2024. 22nd Century has completed 2 acquisitions, including GVB Biopharma and RX Pharmatech.
- Headquarter Williamsville, United States
- Employees 56 as on 31 Dec, 2024
- Stage Public
-
Sectors
Industrial Goods & Manufacturing
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name 22Nd Century Group, Inc
-
Annual Revenue
$24.38 M (USD)-24.29as on Dec 31, 2024
-
Net Profit
-$15.16 M (USD)89.23as on Dec 31, 2024
-
EBITDA
-$12.54 M (USD)66.25as on Dec 31, 2024
-
Latest Funding Round
$20 M (USD), Post-IPO
Mar 21, 2026
-
Investors
European Union
& 1 more
-
Employee Count
56
as on Dec 31, 2024
-
Investments & Acquisitions
GVB Biopharma
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of 22nd Century
22nd Century is a publicly listed company on the NASDAQ with ticker symbol XXII in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of 22nd Century
Unlock access to complete
Unlock access to complete
Funding Insights of 22nd Century
Investors in 22nd Century
22nd Century has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Montrose Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments in US tech and life sciences are targeted.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for 22nd Century
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by 22nd Century
22nd Century has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include GVB Biopharma and RX Pharmatech.
Investment portfolio details for 22nd Century
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cannabis extracts and white label solutions are provided globally.
|
Locked | Locked | 2016 | Locked | |
|
Cannabis-based products are cultivated and produced by RX Pharmatech.
|
Locked | Locked | 2016 | Locked |
Complete acquisition details for 22nd Century
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - 22nd Century
Detailed financials for 22nd Century
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
22Nd Century Comparisons
Peer comparison for 22nd Century
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of 22nd Century
Detailed competitors of 22nd Century
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on 22Nd Century
Complete news archive for 22nd Century
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 22nd Century
22nd Century was founded in 1998 and raised its 1st funding round 13 years after it was founded.
22nd Century is headquartered in Williamsville, United States. It is registered at Williamsville, New York, United States.
As of Dec 31, 2024, the latest employee count at 22nd Century is 56.
Annual revenue of 22nd Century is $24.38M as on Dec 31, 2024.
22nd Century manufacturer of nicotine products, focusing on industrial goods and manufacturing, and manufacturing services. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Yes, 22nd Century is publicly traded on NASDAQ under the ticker symbol XXII.
22nd Century has made 2 acquisitions, including GVB Biopharma, and RX Pharmatech.
22nd Century has 2 investors. Key investors include European Union, and Montrose Capital Partners.
The ticker symbol of 22nd Century is XXII on NASDAQ.